Market Cap

Lin BioScience, Inc. Market Capitalization:

TW$7.23 Billion

TWD as of July 1, 2024

US$222.2 Million

business Lin BioScience, Inc. Company Profile

Lin BioScience, Inc. Main Stock Listing

TWSE: 6696

Market Capitalization History of Lin BioScience, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $622.07 B
Vertex Pharmaceuticals Incorporated $121.36 B
Regeneron Pharmaceuticals, Inc. $115.11 B
CSL Limited $95.75 B
Marinomed Biotech AG $75.67 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of Lin BioScience, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2024 TW$8.91 B -27.55%
Jan. 1, 2023 TW$12.29 B -19.10%
Jan. 1, 2022 TW$15.20 B 93.61%
Jan. 1, 2021 TW$7.85 B 119.04%
Jan. 1, 2020 TW$3.58 B 26.72%
Jan. 1, 2019 TW$2.83 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Lin BioScience, Inc. Categories

Taiwan languages Healthcare languages Biotechnology
Taiwan Healthcare Taiwan Biotechnology

Stocks & Indices

Lin BioScience, Inc. has the following listings and related stock indices.


Stock: TWSE: 6696

Stock: MYX: 5789

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.